STOCK TITAN

DENTSPLY SIRONA (XRAY) SVP logs tax-withholding stock disposals on equity vesting

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. senior vice president and Chief Supply Chain Officer Robert Anthony Johnson reported share dispositions that were made to cover tax obligations, not open-market sales. On March 4, 2026, 1,026 common shares were withheld at $13.44 per share, leaving 117,176.146 shares held directly.

On March 3, 2026, two similar tax-withholding transactions occurred, with 3,229 and 4,481 common shares withheld at $13.30 per share. Footnotes explain these shares were retained by the company to satisfy taxes due upon vesting of previously granted restricted and performance-based stock units.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Johnson Robert Anthony

(Last) (First) (Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NC 28222

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Supply Chain Office
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/03/2026 F 3,229(1) D $13.3 122,683.146 D
Common Stock 03/03/2026 F 4,481(2) D $13.3 118,202.146 D
Common Stock 03/04/2026 F 1,026(2) D $13.44 117,176.146 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld to cover taxes related to the vesting of the reporting person's Performance-Based Restricted Stock Units and dividend equivalent units previously reported in Table I.
2. Shares withheld to cover taxes related to the vesting of the reporting person's Restricted Stock Units and dividend equivalent units previously reported in Table I.
/s/ Jessica Nielsen Causey, Attorney-In-Fact for Robert Anthony Johnson 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DENTSPLY SIRONA (XRAY) executive Robert Johnson report in this Form 4?

Robert Anthony Johnson reported share disposals used to cover tax obligations from vesting equity awards. The transactions involved common stock withheld by the company rather than open-market sales, reflecting routine tax-withholding related to previously granted restricted and performance-based stock units.

Were the DENTSPLY SIRONA (XRAY) Form 4 transactions open-market stock sales?

No, the reported transactions were not open-market stock sales. They were tax-withholding dispositions, where shares were withheld by the company to cover taxes owed upon vesting of Johnson’s restricted stock units and performance-based restricted stock units, as described in the footnotes.

How many DENTSPLY SIRONA (XRAY) shares did Robert Johnson hold after the latest transaction?

After the March 4, 2026 tax-withholding disposition, Johnson directly held 117,176.146 shares of DENTSPLY SIRONA common stock. This figure reflects his remaining direct ownership following shares withheld to satisfy tax obligations on vesting equity awards.

What prices were used for the DENTSPLY SIRONA (XRAY) tax-withholding share dispositions?

The tax-withholding dispositions used prices of $13.44 per share for 1,026 shares on March 4, 2026, and $13.30 per share for two March 3, 2026 transactions involving 3,229 and 4,481 common shares related to vesting equity awards.

Why were DENTSPLY SIRONA (XRAY) shares withheld from Robert Johnson’s equity awards?

Shares were withheld to cover taxes generated by the vesting of Johnson’s performance-based restricted stock units, restricted stock units, and associated dividend equivalent units. Instead of paying cash for taxes, a portion of the vested shares was retained by the company.

What role does Robert Johnson hold at DENTSPLY SIRONA (XRAY)?

Robert Anthony Johnson serves as senior vice president and Chief Supply Chain Officer at DENTSPLY SIRONA Inc. The Form 4 reports his equity-related tax-withholding share dispositions while confirming his continuing direct ownership stake in the company’s common stock.
Dentsply Sirona Inc

NASDAQ:XRAY

XRAY Rankings

XRAY Latest News

XRAY Latest SEC Filings

XRAY Stock Data

2.66B
198.28M
Medical Instruments & Supplies
Dental Equipment & Supplies
Link
United States
CHARLOTTE